Circadian, Reward, and Emotion Systems in Teens prospective longitudinal study: protocol overview of an integrative reward-circadian rhythm model of first onset of bipolar spectrum disorder in adolescence.
Adversity
Bipolar disorder
Circadian rhythms
Depression
Ecological momentary assessment
Hypo/mania
Reward responsiveness
Sleep
Stress
fMRI
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
17 08 2023
17 08 2023
Historique:
received:
22
06
2023
accepted:
08
08
2023
medline:
21
8
2023
pubmed:
18
8
2023
entrez:
17
8
2023
Statut:
epublish
Résumé
Bipolar spectrum disorders (BSDs) are associated with a heightened sensitivity to rewards and elevated reward-related brain function in cortico-striatal circuitry. A separate literature documents social and circadian rhythm disruption in BSDs. Recently, integrated reward-circadian models of BSDs have been proposed. These models draw on work indicating that the two systems influence each other and interact to affect mood functioning. When dysregulated, reward and circadian system signaling may combine to form a positive feedback loop, whereby dysregulation in one system exacerbates dysregulation in the other. Project CREST (Circadian, Reward, and Emotion Systems in Teens) provides a first systematic test of reward-circadian dysregulation as a synergistic and dynamic vulnerability for first onset of BSD and increases in bipolar symptoms during adolescence. This NIMH-funded R01 study is a 3-year prospective, longitudinal investigation of approximately 320 community adolescents from the broader Philadelphia area, United States of America. Eligible participants must be 13-16 years old, fluent in English, and without a prior BSD or hypomanic episode. They are being selected along the entire dimension of self-reported reward responsiveness, with oversampling at the high tail of the dimension in order to increase the likelihood of BSD onsets. At Times 1-6, every 6 months, participants will complete assessments of reward-relevant and social rhythm disruption life events and self-report and diagnostic assessments of bipolar symptoms and episodes. Yearly, at Times 1, 3, and 5, participants also will complete self-report measures of circadian chronotype (morningness-eveningness) and social rhythm regularity, a salivary dim light melatonin onset (DLMO) procedure to assess circadian phase, self-report, behavioral, and neural (fMRI) assessments of monetary and social reward responsiveness, and a 7-day ecological momentary assessment (EMA) period. During each EMA period, participants will complete continuous measures of sleep/wake and activity (actigraphy), a daily sleep diary, and three within-day (morning, afternoon, evening) measures of life events coded for reward-relevance and social rhythm disruption, monetary and social reward responsiveness, positive and negative affect, and hypo/manic and depressive symptoms. The fMRI scan will occur on the day before and the DLMO procedure will occur on the first evening of the 7-day EMA period. This study is an innovative integration of research on multi-organ systems involved in reward and circadian signaling in understanding first onset of BSD in adolescence. It has the potential to facilitate novel pharmacological, neural, and behavioral interventions to treat, and ideally prevent, bipolar conditions.
Sections du résumé
BACKGROUND
Bipolar spectrum disorders (BSDs) are associated with a heightened sensitivity to rewards and elevated reward-related brain function in cortico-striatal circuitry. A separate literature documents social and circadian rhythm disruption in BSDs. Recently, integrated reward-circadian models of BSDs have been proposed. These models draw on work indicating that the two systems influence each other and interact to affect mood functioning. When dysregulated, reward and circadian system signaling may combine to form a positive feedback loop, whereby dysregulation in one system exacerbates dysregulation in the other. Project CREST (Circadian, Reward, and Emotion Systems in Teens) provides a first systematic test of reward-circadian dysregulation as a synergistic and dynamic vulnerability for first onset of BSD and increases in bipolar symptoms during adolescence.
METHODS
This NIMH-funded R01 study is a 3-year prospective, longitudinal investigation of approximately 320 community adolescents from the broader Philadelphia area, United States of America. Eligible participants must be 13-16 years old, fluent in English, and without a prior BSD or hypomanic episode. They are being selected along the entire dimension of self-reported reward responsiveness, with oversampling at the high tail of the dimension in order to increase the likelihood of BSD onsets. At Times 1-6, every 6 months, participants will complete assessments of reward-relevant and social rhythm disruption life events and self-report and diagnostic assessments of bipolar symptoms and episodes. Yearly, at Times 1, 3, and 5, participants also will complete self-report measures of circadian chronotype (morningness-eveningness) and social rhythm regularity, a salivary dim light melatonin onset (DLMO) procedure to assess circadian phase, self-report, behavioral, and neural (fMRI) assessments of monetary and social reward responsiveness, and a 7-day ecological momentary assessment (EMA) period. During each EMA period, participants will complete continuous measures of sleep/wake and activity (actigraphy), a daily sleep diary, and three within-day (morning, afternoon, evening) measures of life events coded for reward-relevance and social rhythm disruption, monetary and social reward responsiveness, positive and negative affect, and hypo/manic and depressive symptoms. The fMRI scan will occur on the day before and the DLMO procedure will occur on the first evening of the 7-day EMA period.
DISCUSSION
This study is an innovative integration of research on multi-organ systems involved in reward and circadian signaling in understanding first onset of BSD in adolescence. It has the potential to facilitate novel pharmacological, neural, and behavioral interventions to treat, and ideally prevent, bipolar conditions.
Identifiants
pubmed: 37592214
doi: 10.1186/s12888-023-05094-z
pii: 10.1186/s12888-023-05094-z
pmc: PMC10436678
doi:
Substances chimiques
Melatonin
JL5DK93RCL
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
602Subventions
Organisme : NIMH NIH HHS
ID : R01 MH126911
Pays : United States
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Sleep. 2003 May 1;26(3):342-92
pubmed: 12749557
Brain Res. 2007 Jan 19;1129(1):34-42
pubmed: 17156761
Nat Rev Neurosci. 2012 Sep;13(9):636-50
pubmed: 22903221
J Prim Prev. 2010 Dec;31(5-6):321-31
pubmed: 21063779
J Clin Psychiatry. 2014 Apr;75(4):e323-31
pubmed: 24500332
Emotion. 2009 Oct;9(5):705-16
pubmed: 19803592
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Psychiatry Res. 1999 Apr 19;86(1):1-8
pubmed: 10359478
Bipolar Disord. 2006 Aug;8(4):382-99
pubmed: 16879139
Bipolar Disord. 2012 Dec;14(8):870-9
pubmed: 23167935
Dev Psychopathol. 2006 Fall;18(4):1055-103
pubmed: 17064429
Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R271-7
pubmed: 16987893
Braz J Psychiatry. 2013 Oct-Dec;35(4):416-31
pubmed: 24402217
Chronobiol Int. 2006;23(1-2):497-509
pubmed: 16687322
Arch Gen Psychiatry. 2005 Sep;62(9):996-1004
pubmed: 16143731
Biol Psychiatry. 2012 Mar 1;71(5):451-7
pubmed: 22137505
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
J Youth Adolesc. 2020 Jul;49(7):1379-1392
pubmed: 31410721
Behav Brain Funct. 2008 Nov 24;4:54
pubmed: 19025655
Curr Psychiatry Rep. 2017 Apr;19(4):21
pubmed: 28321642
Clin Psychol (New York). 2009 Jun 1;16(2):206-226
pubmed: 20161008
J Clin Child Adolesc Psychol. 2021 Sep-Oct;50(5):579-595
pubmed: 32401546
Arch Gen Psychiatry. 1988 Oct;45(10):948-52
pubmed: 3048226
J Clin Psychol. 2008 Apr;64(4):482-500
pubmed: 18322928
Bipolar Disord. 2022 May;24(3):232-263
pubmed: 34850507
Chronobiol Int. 2015 Apr;32(3):376-84
pubmed: 25410882
Cognit Ther Res. 2013 Feb;37(1):139-149
pubmed: 23459574
Clin Psychol Sci. 2016 Sep;4(5):867-881
pubmed: 27747141
Bipolar Disord. 2008 Mar;10(2):310-22
pubmed: 18271911
Nat Neurosci. 2007 Jun;10(6):787-91
pubmed: 17468751
J Abnorm Psychol. 2009 Aug;118(3):459-71
pubmed: 19685944
Bipolar Disord. 2008 Jun;10(4):520-9
pubmed: 18452448
J Nerv Ment Dis. 1990 Feb;178(2):120-6
pubmed: 2299336
J Abnorm Psychol. 2012 Feb;121(1):16-27
pubmed: 21668080
J Abnorm Psychol. 2021 Nov;130(8):886-898
pubmed: 34843292
J Abnorm Psychol. 1981 Oct;90(5):381-437
pubmed: 7298991
J Abnorm Child Psychol. 2014 May;42(4):527-38
pubmed: 24014162
Science. 2016 Aug 12;353(6300):687-90
pubmed: 27516598
Am J Psychiatry. 2003 May;160(5):999-1001
pubmed: 12727708
Cognit Ther Res. 2009 Dec;33(6):552-569
pubmed: 20376291
Neurosci Biobehav Rev. 2019 Apr;99:251-274
pubmed: 30721729
Psychol Med. 2000 Sep;30(5):1005-16
pubmed: 12027038
Biol Psychol. 2012 Dec;91(3):334-41
pubmed: 22960270
Curr Opin Neurobiol. 2010 Apr;20(2):236-41
pubmed: 20167473
J Psychiatr Res. 2017 Nov;94:131-138
pubmed: 28711776
J Abnorm Psychol. 2008 Feb;117(1):164-70
pubmed: 18266494
Physiol Behav. 2015 May 1;143:58-69
pubmed: 25708277
Arch Gen Psychiatry. 1998 Aug;55(8):702-7
pubmed: 9707380
J Abnorm Psychol. 2010 Aug;119(3):610-5
pubmed: 20677850
JCPP Adv. 2022 Mar;2(1):
pubmed: 36714682
Assessment. 2020 Jul;27(5):1045-1069
pubmed: 31416336
Annu Rev Clin Psychol. 2015;11:213-50
pubmed: 25581235
Nat Methods. 2019 Jan;16(1):111-116
pubmed: 30532080
J Clin Child Adolesc Psychol. 2019 Jul-Aug;48(4):669-683
pubmed: 30908092
Am J Psychiatry. 2009 Jul;166(7):795-804
pubmed: 19448190
Sleep. 1982;5(4):389-99
pubmed: 7163726
J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):550-560
pubmed: 16601399
Bipolar Disord. 2009 Feb;11(1):89-94
pubmed: 19133971
Bipolar Disord. 2000 Dec;2(4):340-6
pubmed: 11252648
Bipolar Disord. 2010 Aug;12(5):459-72
pubmed: 20712747
Dev Psychopathol. 2005 Summer;17(3):715-34
pubmed: 16262989
Cold Spring Harb Symp Quant Biol. 2007;72:293-9
pubmed: 18419286
Health Psychol. 2000 Nov;19(6):586-92
pubmed: 11129362
Arch Gen Psychiatry. 1986 May;43(5):421-9
pubmed: 3964020
Cold Spring Harb Symp Quant Biol. 2007;72:579-97
pubmed: 18419318
J Clin Psychol. 2008 Jan;64(1):83-102
pubmed: 18161034
Soc Cogn Affect Neurosci. 2017 Jun 1;12(6):928-936
pubmed: 28338785
Psychol Med. 2006 Oct;36(10):1363-73
pubmed: 16834822
Brain Behav Immun Health. 2023 May 29;30:100643
pubmed: 37304334
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6386-91
pubmed: 16606840
Clin Psychol Sci. 2016 May;4(3):418-432
pubmed: 27429864
Bipolar Disord. 2005 Apr;7(2):176-86
pubmed: 15762859
Neurosci Lett. 2000 Feb 25;280(3):199-202
pubmed: 10675795
Psychiatry Clin Neurosci. 2019 Dec;73(12):754-760
pubmed: 31490607
Behav Ther. 2009 Jun;40(2):131-41
pubmed: 19433144
J Adolesc. 2014 Feb;37(2):165-74
pubmed: 24439622
Cognit Ther Res. 2008 Aug 1;32(4):507-525
pubmed: 20360998
Psychiatry Res. 2014 Oct 30;224(1):22-7
pubmed: 25092525
Sleep Med Rev. 2016 Feb;25:52-73
pubmed: 26163057
Bipolar Disord. 2012 Jun;14(4):375-410
pubmed: 22631621
Cognit Ther Res. 2006;30(3):377-395
pubmed: 20198117
J Abnorm Psychol. 2012 Aug;121(3):592-601
pubmed: 22775582
J Abnorm Psychol. 2008 May;117(2):268-277
pubmed: 18489203
Pediatrics. 2005 Jun;115(6):1555-61
pubmed: 15930216
Arch Gen Psychiatry. 1991 Sep;48(9):807-12
pubmed: 1929771
Pediatrics. 2001 Aug;108(2):E31
pubmed: 11483841
J Abnorm Psychol. 2007 Feb;116(1):105-15
pubmed: 17324021
Soc Cogn Affect Neurosci. 2014 Nov;9(11):1798-807
pubmed: 24273075
Sleep Med Rev. 2017 Aug;34:46-58
pubmed: 27524206
J Pers Soc Psychol. 1991 Jul;61(1):115-21
pubmed: 1890582
Cognit Ther Res. 2008 Oct 1;32(5):702-713
pubmed: 20360996
J Abnorm Psychol. 2012 May;121(2):339-351
pubmed: 22004113
J Neurosci. 2006 Jun 21;26(25):6885-92
pubmed: 16793895
J Abnorm Psychol. 2008 Feb;117(1):154-63
pubmed: 18266493
Arch Gen Psychiatry. 2001 May;58(5):510-2
pubmed: 11343533
Psychol Med. 2016 Nov;46(15):3187-3198
pubmed: 27573157
J Affect Disord. 2017 Jul;216:3-16
pubmed: 28237133
J Child Adolesc Psychopharmacol. 2015 Nov;25(9):711-21
pubmed: 26469133
Curr Biol. 2017 Aug 21;27(16):2465-2475.e3
pubmed: 28781050
Biol Psychiatry. 2008 Apr 1;63(7):693-8
pubmed: 17919457
Front Psychiatry. 2016 Jan 12;6:187
pubmed: 26793129
J Am Acad Child Adolesc Psychiatry. 2010 Feb;49(2):162-72.e1-5
pubmed: 20215938
Biol Psychiatry. 2018 Jun 15;83(12):987-996
pubmed: 29373120
Neuropsychology. 1998 Jan;12(1):115-24
pubmed: 9460739
Neuroimage Clin. 2019;24:102018
pubmed: 31670069
Int J Cogn Ther. 2009;2(2):176-187
pubmed: 20360995
Neuropsychopharmacology. 2014 Jul;39(8):1914-23
pubmed: 24535101
Sleep. 2018 Jun 1;41(6):
pubmed: 29608755
Nat Commun. 2016 May 23;7:11662
pubmed: 27210069
J Affect Disord. 2012 Aug;139(3):264-72
pubmed: 22381951
J Affect Disord. 2013 Jun;148(2-3):161-9
pubmed: 23477848
Sleep Med Rev. 2011 Aug;15(4):259-67
pubmed: 21237680
J Clin Psychiatry. 2006 Oct;67(10):1551-60
pubmed: 17107246
Psychol Addict Behav. 2004 Sep;18(3):275-83
pubmed: 15482083
Behav Ther. 2016 Sep;47(5):600-621
pubmed: 27816074
J Clin Psychol. 2008 Apr;64(4):368-81
pubmed: 18302291
Soc Cogn Affect Neurosci. 2019 Nov 1;14(11):1159-1166
pubmed: 31680163
Biol Psychiatry. 1996 Aug 15;40(4):279-83
pubmed: 8871774
Neuroimage. 2017 Nov 1;161:80-93
pubmed: 28803940
Neuropsychopharmacology. 2015 Feb;40(3):658-66
pubmed: 25139065
Int J Chronobiol. 1976;4(2):97-110
pubmed: 1027738
Psychoneuroendocrinology. 2004 Nov;29(10):1250-9
pubmed: 15288704
J Biol Rhythms. 2004 Jun;19(3):248-57
pubmed: 15155011
J Psychosom Res. 1998 Jul;45(1):5-13
pubmed: 9720850
Sleep. 1992 Oct;15(5):461-9
pubmed: 1455130
Sci Rep. 2017 Jun 12;7(1):3216
pubmed: 28607474
Soc Cogn Affect Neurosci. 2016 Jun;11(6):934-44
pubmed: 26833919
Sleep. 2012 Feb 01;35(2):287-302
pubmed: 22294820
Bipolar Disord. 2016 Mar;18(2):164-73
pubmed: 26946486
Chronobiol Int. 1989;6(1):93-102
pubmed: 2706705
J Abnorm Child Psychol. 2004 Aug;32(4):435-51
pubmed: 15305548
Assessment. 2011 Sep;18(3):263-83
pubmed: 21697139
J Youth Adolesc. 1988 Apr;17(2):117-33
pubmed: 24277579
J Abnorm Psychol. 2000 Nov;109(4):721-7
pubmed: 11195996
J Neurosci. 2017 Nov 8;37(45):10855-10866
pubmed: 29118215
Brain Cogn. 1987 Apr;6(2):175-83
pubmed: 3593557
Annu Rev Clin Psychol. 2012;8:243-67
pubmed: 22077912
Biol Psychiatry. 1997 Nov 15;42(10):948-55
pubmed: 9359982
J Affect Disord. 2007 Apr;99(1-3):147-54
pubmed: 17030064
Neuroreport. 2001 Dec 4;12(17):3683-7
pubmed: 11726774
Clin Psychol Rev. 2006 Oct;26(6):679-94
pubmed: 16904251
J Abnorm Psychol. 2015 Nov;124(4):944-952
pubmed: 26595474
Curr Opin Neurobiol. 2016 Oct;40:81-85
pubmed: 27420376
Sleep. 2013 Nov 01;36(11):1617-24
pubmed: 24179293
J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):416-21
pubmed: 8774407
Arch Gen Psychiatry. 1978 Jul;35(7):837-44
pubmed: 678037
Clin Psychol (New York). 2009 Dec 1;16(4):449-469
pubmed: 20161456
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715
Sleep Med Rev. 2015 Apr;20:46-58
pubmed: 25060968